Q1 2026 Holdings
Filed 2026-05-15 | 88 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $143.2M | 8,009,447 | 4.8% |
| Guardant Health Inc | DEBT 1.250% 2/1 | 40131MAD1 | $102.6M | $60,954,000 | 3.4% |
| Repligen Corp | NOTE 1.000%12/1 | 759916AD1 | $98.7M | $101,000,000 | 3.3% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $91.8M | $100,381,000 | 3.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $85.9M | 652,121 | 2.9% |
| Glaukos Corp(GKOS) | COM | 377322102 | $82.2M | 763,505 | 2.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $78.9M | 1,986,768 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $77.8M | 1,338,452 | 2.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $75.5M | 899,364 | 2.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $73.9M | 2,347,583 | 2.5% |
| Irhythm Holdings Inc(IRTC) | COM | 450056106 | $72.0M | 610,192 | 2.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $71.8M | 700,429 | 2.4% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $69.3M | 1,818,665 | 2.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $66.7M | 984,783 | 2.2% |
| Alphatec Hldgs Inc | NOTE 0.750% 3/1 | 02081GAD4 | $63.4M | $61,621,000 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $62.0M | 84,939 | 2.1% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $56.1M | 1,455,123 | 1.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $55.0M | 2,471,199 | 1.8% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $52.7M | 3,206,574 | 1.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $47.1M | 182,425 | 1.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $47.1M | 932,823 | 1.6% |
| Guardant Health Inc(GH) | COM | 40131M109 | $46.2M | 499,712 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $45.7M | 92,915 | 1.5% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $44.9M | 3,592,999 | 1.5% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $44.6M | 1,492,467 | 1.5% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $43.3M | 1,016,562 | 1.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $43.0M | 1,356,082 | 1.4% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $41.7M | 5,617,402 | 1.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $40.3M | 478,667 | 1.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $39.4M | 539,708 | 1.3% |
| Caredx Inc(CDNA) | COM | 14167L103 | $37.7M | 2,173,146 | 1.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $35.6M | 77,297 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $34.9M | 677,570 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $34.6M | 105,352 | 1.2% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $32.7M | 329,391 | 1.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $32.1M | 959,259 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $30.5M | 1,681,998 | 1.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $29.0M | 10,240,164 | 1.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $28.3M | 229,215 | 0.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $28.1M | 337,559 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.1M | 497,020 | 0.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $27.1M | 1,750,766 | 0.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $27.0M | 310,628 | 0.9% |
| Danaher Corp del(DHR) | COM | 235851102 | $26.4M | 139,327 | 0.9% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $26.3M | 463,600 | 0.9% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $26.2M | 847,151 | 0.9% |
| Natera Inc(NTRA) | COM | 632307104 | $25.8M | 129,000 | 0.9% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $25.6M | 1,752,798 | 0.9% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $24.0M | 3,134,922 | 0.8% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $23.7M | 3,988,989 | 0.8% |